Annual EBIT
-$2.75 M
+$793.00 K+22.41%
31 December 2023
Summary:
China Pharma Holdings annual earnings before interest & taxes is currently -$2.75 million, with the most recent change of +$793.00 thousand (+22.41%) on 31 December 2023. During the last 3 years, it has fallen by -$172.60 thousand (-6.71%). CPHI annual EBIT is now -110.45% below its all-time high of $27.77 million.CPHI EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBIT
-$1.08 M
+$306.20 K+22.03%
30 September 2024
Summary:
China Pharma Holdings quarterly earnings before interest & taxes is currently -$1.08 million, with the most recent change of +$306.20 thousand (+22.03%) on 30 September 2024. Over the past year, it has dropped by -$372.40 thousand (-52.35%). CPHI quarterly EBIT is now -110.63% below its all-time high of $10.19 million, reached on 30 September 2008.CPHI Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBIT
-$4.57 M
-$372.40 K-8.87%
30 September 2024
Summary:
China Pharma Holdings TTM earnings before interest & taxes is currently -$4.57 million, with the most recent change of -$372.40 thousand (-8.87%) on 30 September 2024. Over the past year, it has dropped by -$1.84 million (-67.30%). CPHI TTM EBIT is now -116.99% below its all-time high of $26.89 million, reached on 31 March 2011.CPHI TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CPHI EBIT Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +22.4% | -52.4% | -67.3% |
| 3 y3 years | -6.7% | -42.3% | -38.0% |
| 5 y5 years | +73.6% | -71.1% | +50.4% |
CPHI EBIT High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -6.7% | +22.4% | -173.3% | +22.0% | -68.8% | at low |
| 5 y | 5 years | -6.7% | +86.5% | -1522.3% | +94.2% | -77.6% | +77.9% |
| alltime | all time | -110.5% | +92.9% | -110.6% | +95.0% | -117.0% | +88.6% |
China Pharma Holdings EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$1.08 M(-22.0%) | -$4.57 M(+8.9%) |
| June 2024 | - | -$1.39 M(+52.1%) | -$4.20 M(+28.6%) |
| Mar 2024 | - | -$913.70 K(-22.7%) | -$3.26 M(+18.8%) |
| Dec 2023 | -$2.75 M(-22.4%) | -$1.18 M(+66.2%) | -$2.75 M(+0.5%) |
| Sept 2023 | - | -$711.40 K(+56.2%) | -$2.73 M(+0.9%) |
| June 2023 | - | -$455.40 K(+14.9%) | -$2.71 M(-10.7%) |
| Mar 2023 | - | -$396.50 K(-66.1%) | -$3.03 M(-14.4%) |
| Dec 2022 | -$3.54 M(+23.8%) | -$1.17 M(+70.1%) | -$3.54 M(+17.3%) |
| Sept 2022 | - | -$686.80 K(-11.8%) | -$3.02 M(-2.4%) |
| June 2022 | - | -$778.40 K(-14.0%) | -$3.09 M(+0.8%) |
| Mar 2022 | - | -$905.10 K(+39.8%) | -$3.07 M(+7.3%) |
| Dec 2021 | -$2.86 M(+11.1%) | -$647.30 K(-15.0%) | -$2.86 M(-13.7%) |
| Sept 2021 | - | -$761.80 K(+1.2%) | -$3.31 M(-5.3%) |
| June 2021 | - | -$752.40 K(+8.1%) | -$3.50 M(+31.0%) |
| Mar 2021 | - | -$696.10 K(-36.8%) | -$2.67 M(+3.8%) |
| Dec 2020 | -$2.57 M(-87.4%) | -$1.10 M(+16.1%) | -$2.57 M(-87.2%) |
| Sept 2020 | - | -$948.80 K(-1345.1%) | -$20.15 M(+1.6%) |
| June 2020 | - | $76.20 K(-112.7%) | -$19.83 M(-4.0%) |
| Mar 2020 | - | -$598.90 K(-96.8%) | -$20.65 M(+1.3%) |
| Dec 2019 | -$20.38 M(+95.8%) | -$18.68 M(+2848.4%) | -$20.38 M(+121.4%) |
| Sept 2019 | - | -$633.40 K(-14.5%) | -$9.21 M(-12.2%) |
| June 2019 | - | -$740.80 K(+123.8%) | -$10.49 M(-1.1%) |
| Mar 2019 | - | -$331.00 K(-95.6%) | -$10.60 M(+1.9%) |
| Dec 2018 | -$10.41 M(-44.1%) | -$7.50 M(+291.6%) | -$10.41 M(-37.2%) |
| Sept 2018 | - | -$1.92 M(+124.0%) | -$16.58 M(-0.7%) |
| June 2018 | - | -$854.90 K(+517.7%) | -$16.70 M(-7.0%) |
| Mar 2018 | - | -$138.40 K(-99.0%) | -$17.96 M(-3.5%) |
| Dec 2017 | -$18.62 M(+132.0%) | -$13.67 M(+572.2%) | -$18.62 M(+133.3%) |
| Sept 2017 | - | -$2.03 M(-3.9%) | -$7.98 M(+6.9%) |
| June 2017 | - | -$2.12 M(+165.2%) | -$7.46 M(-1.0%) |
| Mar 2017 | - | -$797.60 K(-73.7%) | -$7.53 M(-6.1%) |
| Dec 2016 | -$8.02 M(-43.4%) | -$3.03 M(+100.2%) | -$8.03 M(-27.0%) |
| Sept 2016 | - | -$1.52 M(-30.8%) | -$10.99 M(+76.0%) |
| June 2016 | - | -$2.19 M(+69.9%) | -$6.24 M(+141.5%) |
| Mar 2016 | - | -$1.29 M(-78.5%) | -$2.58 M(-48.7%) |
| Dec 2015 | -$14.18 M(-63.3%) | -$6.00 M(-285.6%) | -$5.03 M(-75.9%) |
| Sept 2015 | - | $3.23 M(+119.8%) | -$20.92 M(-30.6%) |
| June 2015 | - | $1.47 M(-139.3%) | -$30.13 M(-24.9%) |
| Mar 2015 | - | -$3.74 M(-82.9%) | -$40.11 M(+3.7%) |
| Dec 2014 | -$38.69 M(+108.0%) | -$21.88 M(+265.7%) | -$38.69 M(+55.0%) |
| Sept 2014 | - | -$5.98 M(-29.7%) | -$24.96 M(+15.2%) |
| June 2014 | - | -$8.51 M(+267.7%) | -$21.66 M(+20.9%) |
| Mar 2014 | - | -$2.31 M(-71.6%) | -$17.91 M(-3.7%) |
| Dec 2013 | -$18.60 M(-414.7%) | -$8.15 M(+203.7%) | -$18.60 M(+57.9%) |
| Sept 2013 | - | -$2.69 M(-43.6%) | -$11.78 M(+57.6%) |
| June 2013 | - | -$4.76 M(+58.7%) | -$7.47 M(+1384.5%) |
| Mar 2013 | - | -$3.00 M(+124.6%) | -$503.50 K(-108.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2012 | $5.91 M(-74.3%) | -$1.34 M(-182.5%) | $5.91 M(-51.6%) |
| Sept 2012 | - | $1.62 M(-26.8%) | $12.21 M(-26.2%) |
| June 2012 | - | $2.21 M(-35.2%) | $16.56 M(-18.7%) |
| Mar 2012 | - | $3.41 M(-31.2%) | $20.36 M(-11.3%) |
| Dec 2011 | $22.97 M(-12.6%) | $4.96 M(-16.8%) | $22.97 M(-9.9%) |
| Sept 2011 | - | $5.97 M(-0.9%) | $25.48 M(-2.5%) |
| June 2011 | - | $6.02 M(+0.0%) | $26.15 M(-2.8%) |
| Mar 2011 | - | $6.02 M(-19.6%) | $26.89 M(+2.4%) |
| Dec 2010 | $26.27 M(+28.8%) | $7.48 M(+12.9%) | $26.27 M(+18.1%) |
| Sept 2010 | - | $6.63 M(-2.1%) | $22.23 M(-6.0%) |
| June 2010 | - | $6.77 M(+25.5%) | $23.66 M(+9.0%) |
| Mar 2010 | - | $5.39 M(+56.4%) | $21.71 M(+6.5%) |
| Dec 2009 | $20.39 M(+3.6%) | $3.45 M(-57.2%) | $20.39 M(-10.8%) |
| Sept 2009 | - | $8.06 M(+67.4%) | $22.87 M(-8.6%) |
| June 2009 | - | $4.81 M(+18.1%) | $25.01 M(+1.7%) |
| Mar 2009 | - | $4.07 M(-31.3%) | $24.59 M(-2.3%) |
| Dec 2008 | $19.67 M(+60.6%) | $5.93 M(-41.8%) | $25.17 M(+4.6%) |
| Sept 2008 | - | $10.19 M(+131.9%) | $24.07 M(+41.6%) |
| June 2008 | - | $4.40 M(-5.6%) | $17.00 M(+6.4%) |
| Mar 2008 | - | $4.65 M(-3.6%) | $15.97 M(+30.4%) |
| Dec 2007 | $12.25 M(+42.1%) | $4.83 M(+54.5%) | $12.25 M(+21.0%) |
| Sept 2007 | - | $3.12 M(-7.2%) | $10.12 M(+11.6%) |
| June 2007 | - | $3.37 M(+260.1%) | $9.07 M(+28.5%) |
| Mar 2007 | - | $934.60 K(-65.3%) | $7.06 M(-11.5%) |
| Dec 2006 | $8.62 M(+103.2%) | $2.70 M(+30.1%) | $7.98 M(+51.1%) |
| Sept 2006 | - | $2.07 M(+53.3%) | $5.28 M(+35.6%) |
| June 2006 | - | $1.35 M(-27.1%) | $3.89 M(+406.7%) |
| Mar 2006 | - | $1.85 M(+169.8%) | $768.60 K(-167.2%) |
| Dec 2005 | $4.24 M(-330.3%) | - | - |
| Sept 2005 | - | $687.50 K(-138.8%) | -$1.14 M(-37.9%) |
| June 2005 | - | -$1.77 M(+4257.7%) | -$1.84 M(+1658.0%) |
| June 2005 | -$1.84 M(+1469.3%) | - | - |
| Mar 2005 | - | -$40.70 K(+133.9%) | -$104.80 K(+72.9%) |
| Dec 2004 | - | -$17.40 K(+62.6%) | -$60.60 K(+38.4%) |
| Sept 2004 | - | -$10.70 K(-70.3%) | -$43.80 K(-63.5%) |
| June 2004 | -$117.40 K(-74.0%) | -$36.00 K(-1128.6%) | -$119.90 K(-71.8%) |
| Mar 2004 | - | $3500.00(-683.3%) | -$425.50 K(-12.9%) |
| Dec 2003 | - | -$600.00(-99.3%) | -$488.50 K(-13.9%) |
| Sept 2003 | - | -$86.80 K(-74.6%) | -$567.60 K(+25.9%) |
| June 2003 | -$450.70 K(-36.9%) | -$341.60 K(+474.1%) | -$450.70 K(+96.4%) |
| Mar 2003 | - | -$59.50 K(-25.3%) | -$229.50 K(-55.6%) |
| Dec 2002 | - | -$79.70 K(-364.8%) | -$516.50 K(-1.5%) |
| Sept 2002 | - | $30.10 K(-125.0%) | -$524.50 K(-26.6%) |
| June 2002 | -$714.80 K | -$120.40 K(-65.3%) | -$714.80 K(+20.3%) |
| Mar 2002 | - | -$346.50 K(+295.1%) | -$594.40 K(+139.8%) |
| Dec 2001 | - | -$87.70 K(-45.3%) | -$247.90 K(+54.7%) |
| Sept 2001 | - | -$160.20 K | -$160.20 K |
FAQ
- What is China Pharma Holdings annual earnings before interest & taxes?
- What is the all time high annual EBIT for China Pharma Holdings?
- What is China Pharma Holdings annual EBIT year-on-year change?
- What is China Pharma Holdings quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for China Pharma Holdings?
- What is China Pharma Holdings quarterly EBIT year-on-year change?
- What is China Pharma Holdings TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for China Pharma Holdings?
- What is China Pharma Holdings TTM EBIT year-on-year change?
What is China Pharma Holdings annual earnings before interest & taxes?
The current annual EBIT of CPHI is -$2.75 M
What is the all time high annual EBIT for China Pharma Holdings?
China Pharma Holdings all-time high annual earnings before interest & taxes is $27.77 M
What is China Pharma Holdings annual EBIT year-on-year change?
Over the past year, CPHI annual earnings before interest & taxes has changed by +$793.00 K (+22.41%)
What is China Pharma Holdings quarterly earnings before interest & taxes?
The current quarterly EBIT of CPHI is -$1.08 M
What is the all time high quarterly EBIT for China Pharma Holdings?
China Pharma Holdings all-time high quarterly earnings before interest & taxes is $10.19 M
What is China Pharma Holdings quarterly EBIT year-on-year change?
Over the past year, CPHI quarterly earnings before interest & taxes has changed by -$372.40 K (-52.35%)
What is China Pharma Holdings TTM earnings before interest & taxes?
The current TTM EBIT of CPHI is -$4.57 M
What is the all time high TTM EBIT for China Pharma Holdings?
China Pharma Holdings all-time high TTM earnings before interest & taxes is $26.89 M
What is China Pharma Holdings TTM EBIT year-on-year change?
Over the past year, CPHI TTM earnings before interest & taxes has changed by -$1.84 M (-67.30%)